Andrew Christopher SILVANUS

Nationality British
Year of selection2010
InstitutionUVSQ
CountryFrance
RiskLife risks

Type of support

Post-Doctoral Fellowship

Granted amount

60 000 €

Duration

1 year

Antibiotic Resistance: Finding New Drugs Faster

The threat posed by drug-resistant bacteria and other microbes is increasing as new strains emerge. Yet, major pharmaceutical companies are not seeking new drugs to fight back. Dr. Andrew Silvanus is developing a faster, easier method of screening candidates for potential new “superdrugs”: starting with natural substances containing molecular structures already known to fight infection, tweaking them in a variety of ways, and testing the results. Silvanus's work has the potential to accelerate vital antibiotic discovery.

To add or modify information on this page, please contact us at the following address: community.research@axa.com